
https://www.science.org/content/blog-post/something-nothing
# Something From Nothing (February 2007)

## 1. SUMMARY

This is a personal blog post by an organic chemist reflecting on the simple pleasures of chemical synthesis while waiting at an airport. The author describes the satisfaction of creating something new that didn't exist before, using the example of synthesizing 2,2-dimethoxypropane from acetone and methanol with acid catalysis—transforming clear liquids into a new compound with different properties. The narrative emphasizes the visceral satisfaction of distillation and particularly the "magic" of watching liquid reactants crystallize into solid products with distinct forms. The tone is reflective and nostalgic, mentioning that the author hasn't done much distillation in recent years and misses it.

## 2. HISTORY

The article's publication in 2007 coincided with broader trends in chemistry and drug discovery that shaped the subsequent decade and a half. The period saw significant evolution in how "making stuff" occurred in pharmaceutical contexts—traditional medicinal chemistry and step-by-step synthesis remained important but faced competition from new modalities.

The timeframe after 2007 witnessed substantial changes: continued migration of chemistry jobs to lower-cost regions, increased automation in synthesis, the rise of biologics and monoclonal antibodies (which don't involve small-molecule crystallization in the same way), and growth in continuous flow chemistry reducing traditional batch distillation. CROs in countries like China and India captured increasing shares of small-molecule synthesis work. Antibody-drug conjugates emerged as a major class requiring hybrid synthesis approaches. The scope of FDA approvals shifted toward biologics; small-molecule NME approvals fluctuated but generally remained important. Discovery timelines lengthened and R&D productivity challenges persisted across the industry.

## 3. PREDICTIONS

The article contains no explicit predictions about biotechnology, drug development, or future scientific trends. It is a personal reflection piece rather than a prognostic essay. The author's musings about the pleasure of crystal formation and distillation are observations about immediate experience, not forecasts about the field's direction.

## 4. INTEREST

Rating: **1/10**

This is a brief personal blog post about the aesthetic pleasures of chemical synthesis with no broader analysis of biotechnology trends, predictions to evaluate, or significant implications for the field. While well-written and reflective, it ranks in the bottom decile for relevance to biotechnology industry analysis.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20070220-something-nothing.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_